Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1/2 1

Status

Recruiting 3Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 516INDUSTRY 178OTHER_GOV 23NIH 18FED 5NETWORK 3

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Prostatic Neoplasms 11Lung Neoplasms 8Neoplasms 7Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Fibrosis 3Urinary Bladder Neoplasms 2Tobacco Use 2Non-Muscle Invasive Bladder Neoplasms 2Motor Activity 2Lymphoma 2Liver Neoplasms 2Keratosis, Actinic 2Hematologic Neoplasms 2Adenocarcinoma Of Esophagus 2Ureteral Neoplasms 1Turcot syndrome 1Tobacco Use Disorder 1Tobacco Use Cessation 1Tinnitus 1Thoracic Neoplasms 1Substance-Related Disorders 1Solitary Pulmonary Nodule 1Smoking 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Patient Compliance 1Ototoxicity 1

Interventions

Simvastatin 1Hydroxychloroquine 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
FED × Carcinoma, Hepatocellular × 1 year × Clear all
NCT05486572 2026-04-21

PREMIUM

VA Office of Research and Development

Phase NA Recruiting
4,700 enrolled
Gastrointestinal

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT05842174 2026-04-16

TAQE

VA Office of Research and Development

Phase 1/2 Recruiting
93 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06061328 2026-02-04

OASIS

VA Office of Research and Development

Phase NA Enrolling by invitation
8,020 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT03654053 2026-01-07

SACRED

VA Office of Research and Development

Phase 3 Active not recruiting
142 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT07019844 2025-07-23

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

VA Office of Research and Development

Recruiting
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡